Related Experiment Videos
Summary
Bromelain, an enzyme in anti-inflammatory drugs, can cause bronchial asthma. Immediate allergic reactions to bromelain inhalation were confirmed by skin tests and blocked by sodium cromoglycate.
Area of Science:
- Allergology
- Pulmonology
- Enzymology
Background:
- Bromelain is a proteolytic enzyme derived from pineapple, used for its anti-inflammatory properties in various medicinal applications.
- Occupational asthma is a significant concern, often triggered by inhaled allergens in the workplace or through medicinal exposure.
Observation:
- Two cases of bronchial asthma are presented, linked to the inhalation of bromelain.
- Patients exhibited immediate hypersensitivity reactions upon exposure to bromelain.
Findings:
- Skin prick tests with bromelain extract yielded positive results in both cases.
- Inhalation challenge tests demonstrated immediate asthmatic responses.
- These immediate reactions were effectively inhibited by sodium cromoglycate.
- Corticosteroids did not prevent the immediate asthmatic reactions induced by bromelain.
Implications:
- This highlights bromelain as a potential occupational or medicinal allergen causing asthma.
- The findings suggest a role for mast cell stabilization (e.g., with sodium cromoglycate) in managing acute bromelain-induced asthma.
- Further investigation into the immunological mechanisms of bromelain hypersensitivity is warranted.